Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55-85
SponsorAristotle University Of Thessaloniki
About this trial
Objective: The purpose of this study is to assess the psychometric qualities of the Montreal Cognitive Assessment (MoCA) version 8.x in Greek, including the MoCA-MIS. We intend to examine the tool's reliability (internal consistency, test-retest reliability) and validity (construct validity, concurrent validity, and known-group validity).
Aim: The findings will support the tool's application for early cognitive impairment identification in clinical and research settings.
Eligibility criteria
Qualifiers
Participants between the ages of 55-85
Fluent in Greek to avoid misunderstandings during the assessment
Participants must be able to provide informed consent
Disqualifiers
History of severe psychiatric or neurological disorders apart from MCI/dementia
Patients having acute medical illnesses
Patients having severe hearing and/or visual impairments
Trial design
Treatments tested in this trial
- Not listed
Trial groups
250 Participants
are grouped into 3 trial groupsSponsors and collaborators
Aristotle University Of Thessaloniki
Lead sponsor
MoCA Clinic and Institute
Collaborator
Source ClinicalTrials.gov